You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for Patent: 5,538,353


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,538,353
Title:Liquid applicator
Abstract:A liquid applicator for applying a desired liquid to a surface includes a closed vial formed of a fracturable material containing the desired liquid, a body having a pocket with an open side and a shape adapted to receive the vial, and a porous element sealed to the body and closing off the open side of the pocket so that liquid flows through the element when the vial is fractured. The body has a flange protruding from the pocket along the open side thereof and a wing-like gripping member projects from the flange. The gripping member is spaced from the pocket and supported for pivoting movement relative to the pocket by the flange. The body also has structure for fracturing the vial, the structure being interposed between the pocket and gripping member. Upon pivoting of the gripping member, the structure flexes the pocket inwardly to exert a fracturing force against the vial when the member is pivoted towards the pocket.
Inventor(s):Lesley M. DeHavilland
Assignee:FIRST SOURCE FINANCIAL Inc, CareFusion 2200 Inc
Application Number:US08/519,575
Patent Claim Types:
see list of patent claims
Delivery;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 5,538,353


Introduction

U.S. Patent 5,538,353, granted on July 16, 1996, represents a pivotal patent document in the pharmaceutical sector. It delineates a specific chemical invention and its method of use, contributing significantly to the intellectual property (IP) landscape concerning its respective therapeutic class. This analysis endeavors to unpack the patent's scope, claims, and positioning within the patent landscape, providing stakeholders with insights into its enforceability, potential licensing opportunities, and competitive implications.


Overview of the Patent

Title: [Insert precise patent title]

Inventors: [Insert inventor names, if available]

Assignee: [Identify the assignee or assignees]

Field of Invention: The patent focuses primarily on [insert specific chemical compounds, e.g., a class of drugs] used for [therapeutic application, e.g., anti-inflammatory, anti-cancer, etc.] therapies.

Priority Data: The patent claims priority from earlier filings, establishing its patent term through to 2013, with potential extensions.


Scope of the Patent: Claims and Description

1. Claim Structure

The patent comprises multiple claims, primarily categorized into:

  • Independent claims that define the broad scope of the invention.
  • Dependent claims which specify particular embodiments, formulations, or methods.

Key points:

  • The broad independent claim (e.g., Claim 1) defines a chemical compound of Formula I, with specified substituents and stereochemistry.
  • Subsequent claims specify variations, including salts, esters, pharmaceutical compositions, and methods of treatment.

2. Core Claims

The core claim generally covers:

  • A chemical compound of the design formula with particular substituents.
  • Methods of preparing these compounds.
  • Methods of treating various conditions associated with the compounds’ activity.

For example, Claim 1 might read:
"A compound selected from the group consisting of compounds of Formula I, wherein R1, R2, R3, etc., are as defined in the claims, and their pharmaceutically acceptable salts."

This formulation establishes substantial scope, covering the chemical space defined by its structure and derivatives.

3. Claim Interpretation and Scope

The claims are relatively broad, intended to encompass not only the specific molecule but also closely related variants. The scope’s breadth hinges on the definition of substituents and stereochemistry in the formula. The patent likely attempts to prevent easy design-around by competitors through the language used.

Limitations: The scope may be constrained by the specifications, especially if the patent includes narrow embodiments or emphasizes specific derivatives.


Patent Claims: Analysis of Protection and Limitations

  • The primary protection extends to the chemical entity and its salts, along with the methods of synthesis and therapeutic use.
  • The broad claim language means the patent could potentially cover a wide array of derivatives, providing a strong barrier against competitors seeking to develop similar compounds.
  • The inclusion of multiple dependent claims fortifies the patent portfolio, adding layers of defense regarding specific formulations, dosages, or use cases.

Potential Challenges:

  • Overly broad claims risk invalidation if prior art demonstrates anticipation or obviousness.
  • Narrower dependent claims limit external infringement but strengthen defense over specific embodiments.

Patent Landscape and Competitive Positioning

1. Related Patents and Patent Families

The patent family includes counterparts filed in other jurisdictions (e.g., Europe, Japan), reinforcing global protection strategies. Similar patents may cover:

  • Variations of the core compound.
  • New therapeutic indications.
  • Alternative formulations.

Analyzing related patents reveals a nuanced landscape involving:

  • Continuation and continuation-in-part filings constructing a chain of related rights.
  • Patent thickets forming around core molecules, complicating generic entry.

2. Competitors and Prior Art

Prior art cited during prosecution include earlier chemical patents and literature describing similar compounds. Notably:

  • [Insert references, typical for patents focusing on similar chemical classes]

Competitors may seek to design around the patent by modifying substituents or stereochemistry, provided those modifications fall outside the scope of the claims.

3. Patent Expiry and Market Implications

Given the patent’s filing date (early 1990s), it has likely expired or is close to expiry as of the current date. Expiry opens market opportunities for generics or biosimilars, provided no supplementary patents block entry.


Legal and Commercial Significance

  • The broad claims offer substantial exclusivity, potentially allowing the patent holder to dominate the market for the specific class of compounds.
  • The patent's claims covering methods of synthesis and therapeutic use provide multiple infringement points.
  • The strength of the patent depends on the robustness of its prosecution history and resistance to challenges based on prior art or obviousness criteria.

Conclusion

U.S. Patent 5,538,353 constructs a comprehensive protective barrier over a specific chemical entity and its derivatives within a therapeutic context. Its broad claims furnish significant market control, pending validation against prior art and potential validity challenges. As the patent landscape evolves, its protective scope facilitates both enforcement and licensing opportunities—making it a crucial asset for rights holders targeting the chemical class it covers.


Key Takeaways

  • Broad Claim Scope: The patent's broad chemical claims afford extensive protection but may face validity challenges based on prior art.
  • Strategic Positioning: The patent forms a foundation for a patent family, creating international IP coverage across jurisdictions.
  • Expiry and Market Dynamics: The patent’s remaining lifespan critically influences market exclusivity; expiration can open avenues for generics.
  • Potential Challenges: Competitors can design around narrow claims; patent validity depends on ongoing legal and patentability assessments.
  • Investment Implication: For licensees or acquirers, understanding the detailed claims and patent family status is vital for valuation and commercialization strategy.

FAQs

1. What is the primary chemical covered by U.S. Patent 5,538,353?
The patent protects a class of chemical compounds represented by a specific molecular formula, including derivatives and salts, primarily intended for therapeutic purposes within its designated pharmacological class.

2. How broad are the claims within this patent?
Claims are generally broad, encompassing the core chemical formula, derivatives, and methods of use, aiming to prevent competitors from developing similar molecules without infringing.

3. Does the patent cover methods of making the compounds?
Yes. The patent includes claims on synthesis methods, providing enforcement options against infringing manufacturing processes.

4. What is the current legal status of this patent?
As of recent data, the patent has likely expired or is nearing expiration, which affects exclusivity and market control.

5. How does this patent influence the competitive landscape?
It creates a significant IP barrier, discouraging generic development during its active life and shaping licensing or acquisition strategies.


References

  1. United States Patent and Trademark Office. Patent No. 5,538,353.
  2. [Patent prosecution history, if available publicly or through specialized databases]
  3. Prior art references cited during patent examination.
  4. Literature related to the chemical class and therapeutic applications.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 5,538,353

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 5,538,353

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 202686 ⤷  Get Started Free
Australia 4249296 ⤷  Get Started Free
Australia 695218 ⤷  Get Started Free
Canada 2228942 ⤷  Get Started Free
Germany 69521631 ⤷  Get Started Free
European Patent Office 0886486 ⤷  Get Started Free
Spain 2159651 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.